Beyond COvid: The discussion Series

Critical conditions: the pharmaceutical industry and the economics of a Covid-19 vaccine

September 4, 2020

Covid-19 has cast a spotlight on the debate around the development, ownership and beneficiaries of vaccines. The World Health Organisation has called upon world leaders to sign up to the Covid-19 Technology Access Pool (C-TAP), while the pharmaceutical industry has lobbied the UK and US governments against any concept of IP sharing, arguing that this reduces incentives to innovate. This session will unpack the debate surrounding patents, innovation, and the public funding of private pharmaceutical companies.